Learn about Amyotrophic Lateral Sclerosis (ALS), its symptoms, risk factors, diagnosis, and current research advancements.
Aperture will advance APRTX-001 as a potential treatment for ALS and frontotemporal dementia, with possible expansion for use ...
The "Euphoria" actor guest stars as a firefighter living with the emotional and physical struggles of ALS in an episode of ...
A bipartisan team of U.S. representatives is pushing for new legislation that aims to understand why veterans are at increased risk of ALS.
An announcement from Tiziana Life Sciences ( ($TLSA) ) is now available. On November 25, 2025, Tiziana Life Sciences announced that its Phase 2 ...
Foralumab is the only fully human anti-CD3 monoclonal antibody (mAb) currently in clinical development. Immunomodulation by intranasal foralumab represents a novel avenue for the treatment of ...
Tiziana Life Sciences (TLSA) announced that its Phase 2 clinical trial evaluating intranasal foralumab in patients with amyotrophic lateral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback